黑料吃瓜群网

Gilead Sciences Australia has launched the Gilead Fellowship Grants Program for the 12th time, with a total funding of $300,000 available to Australian medical researchers.

The program is open for innovative projects with a clinical but 鈥榬eal-world鈥� focus with funding available for research in five key areas: HIV, chronic viral hepatitis, haematological oncology, solid tumours (especially breast, lung and bladder) and invasive fungal infections.

Innovative local studies are important for improving patient outcomes locally and to inform care pathways and public health policy. However, these projects can fall outside of traditional grant funding criteria. To bridge this gap, Gilead Sciences has provided over 70 Fellowship Grants for clinical and social investigation and research across urban and rural Australia.

Previous Gilead Fellowship Grants Program winner Associate Professor Catherine MacPhail, School of Health and Society at the University of Wollongong, said, 鈥淚n Australia, we are getting closer to eliminating HIV. However, gaps remain and more work is needed to ensure everyone benefits. The Gilead Fellowship Grants Program has enabled us to begin the next phase of our research investigating Australian women鈥檚 access to information on pre-exposure prophylaxis for HIV prevention, a population that has not yet benefited from advances in HIV prevention technologies.鈥�

Dr Paul Slade, Senior Medical Director, Gilead Sciences ANZ, said, 鈥淭he Gilead Fellowship Grants Program aims to provide Australian researchers who are working across the spectrum of the healthcare ecosystem to identify and address the unmet need. We encourage anyone who is working in the focus areas to review the application process and apply.鈥�

Applicants can apply through the Gilead website at . The Gilead Fellowship Grants Program applications are open from 5 June until 18 August 2023.

Image credit: iStockphoto.com/ADragan